Clinical Trial Update: Study on Ginkgo Biolba Extract Fifty and Mild Cognitive Impairment Associated With CSVD [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for Ginkgo biloba extract in mild cognitive impairment associated with cerebral small vessel disease; the study is not yet recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Ginkgo biloba extract (Ginkgo biloba extract)

Snippet

Sponsor: Beijing Tiantan Hospital | Conditions: Mild Cognitive Impairment | Phase 4 | Status: NOT_YET_RECRUITING